http://click.communications.macquarie.com/?qs=8cfab95162e779c48ae4f2e617555426e15af6aecefcbc7471b77d7caf84d55ead4db10acaf06d221735b6c02a9f69fd69bf1497ef55efa7courtesy of macquarie .
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
